During LC advancement, tumor cells via expressing PD-1 and PD-L1 transform the tumor microenvironment into immunosuppression, ultimately inducing tumor cells evading the surveillance of the immune system and motivating tumor progression [12]. This evidence concerns the gene PDCD1 and neoplasm.